Deals Update
Executive Summary
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
You may also be interested in...
EU Ministers Want Decisive Action On Medicines Access & Shortages
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.
Bio-Thera Gets Chinese Nod To Proceed On Ustekinumab
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.
Can Synthetic CBD Overcome Cannabis Stigma And Break EU Novel Foods Deadlock?
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: